GLPBio

TGF-β / Smad Signaling

Read More about this category

Transforming growth factor-beta (TGF-beta) is a multifunctional cytokine that regulates proliferation, migration, differentiation, and survival of many different cell types. Deletion or mutation of different members of the TGF-β family have been shown to cause vascular remodeling defect and absence of mural cell formation, leading to embryonic lethality or severe vascular disorders. TGF-β induces smooth muscle differentiation via Notch or SMAD2 and SMAD3 signaling in ES cells or in a neural crest stem cell line. TGF-β binds to TGF-βRI and to induce phosphorylation of SMAD2/3, thereby inhibiting proliferation, tube formation, and migration of endothelial cells (ECs).

TGF-β is a pluripotent cytokine with dual tumour-suppressive and tumour-promoting effects. TGF-β induces the epithelial-to-mesenchymal transition (EMT) leading to increased cell plasticity at the onset of cancer cell invasion and metastasis.

Research Areas

Products Related to TGF-β / Smad Signaling(379)

  • GC74326 structure
    GC74326MPSD TFA
    Purity: >98.00%

    MPSD TFA (MARCKS-ED TFA) es la forma de sal de TFA de MPSD.

  • GC74417 structure
    GC74417PKCθ pseudosubstrate peptide inhibitor,myristoylated TFA
    Purity: >98.00%

    PKCθ pseudosubstrate peptide inhibitor,myristoylated TFA es un péptido sintético que puede ser usado para estudiar el mecanismo de acción de PKCθ.

  • GC74419 structure
    GC74419N-myristoyl-RKRTLRRL
    CAS: 152246-40-7
    Purity: >99.00%

    N-myristoyl-RKRTLRRL inhila la Unión de sustrpkc.

  • GC74516 structure
    GC74516Bintrafusp alfa
    CAS: 1918149-01-5
    Purity: >97.00%

    Bintrafusp alfa (M 7824) es la primera proteína de fusión bifuncional en su clase compuesta del dominio extracelular de TGF- - - RII fusiona a un ligligde IgG1 mAb humano que bloquea la muerte celular programada.

  • GC74573 structure
    GC74573Livmoniplimab
    CAS: 2412004-88-5
    Purity: >99.00%

    Livmoniplimab (ABBV-151) es un anticuerpo monoclonal contra GARP/TGF- − 1 que puede inhibir la liberación de TGF- − 1 activo.

  • GC74617 structure
    GC74617SHR-1701
    CAS: 2891860-17-4
    Purity: >99.00%

    SHR-1701 (Retlirafusp alfa) es una proteína de fusión bifuncional dirigida a PD-L1 y TGF-β para la investigación del cáncer.

  • GC79115 structure
    GC79115ROCK2-IN-12
    CAS: 3086603-12-2
    Purity: >98.00%

    ROCK2-IN-12 (Compound A25) is a selective ROCK2 inhibitor with an IC 50 of 7.0 nM for ROCK2 over ROCK1.

  • GC79116 structure
    GC79116NRL-1049 dihydrochloride
    CAS: 1973494-17-5
    Purity: >99.00%

    NRL-1049 dihydrochloride (BA-1049) is a selective and orally active rho-associated protein kinase 2 ( ROCK2 ) inhibitor with an IC 50 of 0.59 μM.

  • GC79186 structure
    GC79186(1S,4R)-CC-90005
    Purity: >99.50%

    (1S,4R)-CC-90005 is the (1S,4R)-enantiomer of CC-90005.

  • GC79187 structure
    GC79187TAT-Epsilon-V1-2 TFA
    Purity: >99.50%

    TAT-Epsilon-V1-2 TFA is a cell-permeable PKCε peptide inhibitor.

  • GC79188 structure
    GC79188TAS1440
    CAS: 2098585-77-2
    Purity: >98.00%

    TAS1440 is an orally active LSD1/KDM1A inhibitor with a human IC 50 of 4.8 nM.

  • GC79707 structure
    GC79707ST1072
    CAS: 1402703-50-7
    Purity: >98.00%

    ST1072 is an inhibitor of CerS4 and CerS6.

  • GC80859 structure
    GC80859RepSox-d 5
    Purity: >98.00%

    RepSox -d 5 (E-616452-d 5 ) is the deuterium labeled RepSox.

  • GC81302 structure
    GC81302Asciminib-NH2
    CAS: 3106065-83-9
    Purity: >97.00%

    Asciminib-NH2 is a BCR-ABL ligand and can be used for the synthesis of PROTACs, such as P19As [1] .

  • GC81341 structure
    GC81341IKVAVC acetate
    Purity: >98.00%

    IKVAVC acetate is a derivative peptide of IKVAV with an artificially added cysteine (Cys) at its C-terminus.

  • GC81342 structure
    GC81342CMF9
    Purity: >98.50%

    CMF9, a cyclic peptide molecule, is an inhibitor of the SMAD2-SMAD4 interaction.

  • GC81350 structure
    GC81350THR-123 TFA
    Purity: >99.50%

    THR-123 TFA is an orally active ALK3 peptide agonist.

  • GC81351 structure
    GC81351Endotrophin (Mus musculus) TFA
    Purity: >96.50%

    Endotrophin (Mus musculus) TFA is an adipokine, a cleavage fragment derived from Collagen VI, whose levels are elevated in adipose tissue and breast tumors of obese mice.

  • GC81352 structure
    GC81352Anti-ALK7 Antibody
    Purity: >97.50%

    Anti-ALK7 Antibody is a monoclonal antibody that targets ALK7.

  • GC81353 structure
    GC81353PF-07868489
    Purity: >99.00%

    PF-07868489 is a recombinant monoclonal antibody targeting GDF2/BMP-9.

  • GC81542 structure
    GC815427-O-Galloyl-D-sedoheptulose
    CAS: 233690-85-2
    Purity: >98.00%

    7-O-Galloyl-D-sedoheptulose is an orally effective polyphenolic compound.

  • GC81672 structure
    GC81672Senkyunolide B
    CAS: 93236-67-0
    Purity: >98.00%

    Senkyunolide B is a phthalide found in Angelica sinensis.

  • GC81880 structure
    GC81880OSU-2S TFA
    Purity: >98.00%

    OSU-2S TFA is a non-immunosuppressive derivative of Fingolimod hydrochloride (FTY720).

  • GC81892 structure
    GC81892Vevorisertib tetrahydrochloride
    Purity: >98.00%

    Vevorisertib tetrahydrochloride (ARQ 751 tetrahydrochloride) is an orally active allosteric AKT inhibitor that blocks AKT phosphorylation.